Get the Stockscreener App
3.16
0.94%
-0.03
After Hours:
3.16
Anixa Biosciences Inc stock is traded at $3.16, with a volume of 195.45K.
It is down -0.94% in the last 24 hours and up +33.90% over the past month.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
See More
Previous Close:
$3.19
Open:
$3.24
24h Volume:
195.45K
Relative Volume:
1.65
Market Cap:
$97.56M
Revenue:
-
Net Income/Loss:
$-10.74M
P/E Ratio:
-9.2941
EPS:
-0.34
Net Cash Flow:
$-6.53M
1W Performance:
+8.97%
1M Performance:
+33.90%
6M Performance:
+4.64%
1Y Performance:
-29.15%
1-Day Range:
$2.97
$3.25
1-Week Range:
$2.65
$3.25
52-Week Range:
$2.07
$4.6682
Anixa Biosciences Inc Stock (ANIX) Company Profile
Name
Anixa Biosciences Inc
Sector
Industry
Phone
408-708-9808
Address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Compare ANIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
3.16 | 97.56M | 0 | -10.74M | -6.53M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.23 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-23-22 | Initiated | Chardan Capital Markets | Buy |
| Apr-12-21 | Initiated | H.C. Wainwright | Buy |
Anixa Biosciences Inc Stock (ANIX) Latest News
Anixa Biosciences Inc (ANIX) Stock: A Closer Look at the Market Potential - The News Heater
Contrasting Eterna Therapeutics (NASDAQ:ERNA) and Anixa Biosciences (NASDAQ:ANIX) - Defense World
Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention - PR Newswire
Insider Buying: Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Purchases 5,000 Shares of Stock - MarketBeat
Anixa biosciences director Arnold Baskies buys $14,100 in stock - MSN
Insider Buying: Arnold Baskies Acquires Additional Shares of Ani - GuruFocus.com
Anixa biosciences director Arnold Baskies buys $14,100 in stock By Investing.com - Investing.com UK
Anixa Biosciences director Titterton buys $8,820 in common stock - MSN
Anixa Biosciences director Titterton buys $8,820 in common stock By Investing.com - Investing.com Australia
Anixa Biosciences’ (ANIX) Buy Rating Reiterated at D. Boral Capital - Defense World
Anixa Biosciences reports progress in cancer vaccine trials - MSN
Anixa Biosciences director Lewis Titterton buys $6,020 worth of stock - Investing.com
Anixa Biosciences director Lewis Titterton buys $6,020 worth of stock By Investing.com - Investing.com Australia
Anixa Biosciences (ANIX) Stock Price, News & Analysis - MarketBeat
Anixa Biosciences director Lewis H. Titterton Jr. buys $15,540 in stock - MSN
Insider Buying: Titterton Lewis H jr Acquires Additional Shares of Anixa Biosciences Inc (ANIX) - GuruFocus.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Purchases $15,540.00 in Stock - MarketBeat
D. Boral Capital Reiterates Buy Rating for Anixa Biosciences (NASDAQ:ANIX) - MarketBeat
AnixaCharting The Path To A Healthier Future - RTTNews
Anixa Biosciences CEO Provides Letter to Shareholders - The Malaysian Reserve
Anixa Biosciences (ANIX) Projected to Post Earnings on Tuesday - Defense World
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Buys $25,700.00 in Stock - MarketBeat
Insider Buying: Titterton Lewis H Jr Acquires Additional Shares of Anixa Biosciences Inc - GuruFocus.com
Anixa biosciences director Lewis Titterton buys shares worth $25,700 - MSN
Anixa biosciences director Lewis Titterton buys shares worth $25,700 By Investing.com - Investing.com Canada
Anixa Biosciences Leads 3 Promising Penny Stocks On US Exchanges - Simply Wall St
Anixa Biosciences president Michael Catelani buys $19,971 in shares By Investing.com - Investing.com Australia
CEO Amit Kumar Increases Stake in Anixa Biosciences Inc - GuruFocus.com
Anixa Biosciences CEO Amit Kumar buys $95,890 in common stock By Investing.com - Investing.com Canada
Anixa Biosciences (ANIX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Insider Buying: Michael Catelani Increases Stake in Anixa Biosci - GuruFocus.com
Insider Buying: Anixa Biosciences, Inc. (NASDAQ:ANIX) CEO Buys 43,000 Shares of Stock - MarketBeat
Anixa Biosciences, Inc. (NASDAQ:ANIX) CFO Michael Catelani Acquires 9,289 Shares - MarketBeat
Anixa Biosciences president Michael Catelani buys $19,971 in shares - Investing.com India
The ‘decade for cancer’: Anixa Biosciences CEO Amit Kumar on cancer vax future - MM+M Online
Anixa Biosciences Inc Stock (ANIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anixa Biosciences Inc Stock (ANIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Titterton Lewis H jr | Director |
Jan 23 '25 |
Buy |
2.91 |
2,000 |
5,820 |
932,334 |
| Titterton Lewis H jr | Director |
Jan 24 '25 |
Buy |
3.00 |
1,000 |
3,000 |
933,334 |
| Titterton Lewis H jr | Director |
Jan 22 '25 |
Buy |
3.01 |
2,000 |
6,020 |
930,334 |
| Titterton Lewis H jr | Director |
Jan 21 '25 |
Buy |
2.59 |
6,000 |
15,540 |
928,334 |
| Titterton Lewis H jr | Director |
Jan 17 '25 |
Buy |
2.57 |
10,000 |
25,700 |
922,334 |
| KUMAR AMIT | Chief Executive Officer |
Jan 15 '25 |
Buy |
2.23 |
43,000 |
95,890 |
559,925 |
| Catelani Michael | President, COO, & CFO |
Jan 15 '25 |
Buy |
2.15 |
9,289 |
19,971 |
44,500 |
| Titterton Lewis H jr | Director |
Oct 22 '24 |
Option Exercise |
2.58 |
16,000 |
41,200 |
912,334 |
| Titterton Lewis H jr | Director |
Jul 30 '24 |
Buy |
3.06 |
21,646 |
66,237 |
890,754 |
| Titterton Lewis H jr | Director |
Jul 31 '24 |
Buy |
3.23 |
5,580 |
18,023 |
896,334 |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):